BEST OF ASH & SABCS 2024, SEATTLE

The Best of ASH & SABCS 2024, Seattle is a CME-accredited, in-person hematology oncology conference featuring leading hematology and breast cancer experts. Expert faculty will place key abstract findings from the 65th ASH Annual Meeting (ASH2023) and the San Antonio Breast Cancer Symposium (SABCS2023) into clinical context and discuss how the results may change the current standards of care for patients with benign and malignant hematologic disorders & breast cancer

Read More »

2023 ANNUAL SYMPOSIUM FOR EVOLVING THERAPIES AND DRUG DEVELOPMENT IN ONCOLOGY

This CME-accredited activity, “2023 Annual Symposium for Evolving Therapies and Drug Development in Oncology: Targeted therapy, immunotherapy and beyond”, is a two-day conference aimed at improving the knowledge and competence of academic and community oncology providers on the biomarker-guided treatment of cancer, and design and conduct of clinical trials in the era of novel therapies.

The activity will use a mix of didactic lectures and panel discussions to highlight various aspects of precision oncology, including current challenges and opportunities in designing clinical trials in the era of novel therapies.

Read More »

BEST OF ASCO 2023, BOISE

  This CME-accredited oncology conference, Best of ASCO 2023, Boise, is designed to improve the care of cancer patients by educating clinicians involved in cancer care.

Read More »

BEST OF ASCO 2023, PORTLAND

  This CME-accredited oncology conference, Best of ASCO 2023, Portland, is designed to improve the care of cancer patients by educating clinicians involved in cancer care.

Read More »